Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

12161 items
12:00 AM, Jun 13, 2000  |  BC Extra | Financial News

EyeTech raises $34 million

EyeTech (New York, N.Y.), which is developing its EYE001 angiogenesis inhibitor to treat wet age-related macular degeneration (AMD), raised $34 million in a venture round. The lead investor was Hingge Hsu with Schroder Ventures Life...
12:00 AM, Jun 13, 2000  |  BC Extra | Financial News

Genmab scoops up $40.5 million

Human antibody company Genmab (Copenhagen, Denmark), raised $40.5 million in the largest European venture round this year. Investors in Genmab included Index Ventures; Apax Europe; Lombard Odier; BankInvest; Lonmodtagernes Dyrtidsfond; Dansk Erhvervsinvestering; and parent Medarex...
12:00 AM, Jun 09, 2000  |  BC Extra | Financial News

Abgenix announces stock split

ABGX, which is developing its XenoMouse human monoclonal antibody technology, will split 2-for-1 on or about July 7. Post-split, ABGX will have 80.6 million shares outstanding. ABGX previously split its shares on a 2-for-1 basis...
12:00 AM, Jun 09, 2000  |  BC Extra | Financial News

ValiGen raises $25 million

The transatlantic bioinformatics, genomics and chimeraplast technology company raised $25 million in a venture round. The lead investor, putting up $7.5 million, was International Biotechnology Trust (LSE:IBT), with ImClone (IMCL) and other investors also participating....
12:00 AM, Jun 08, 2000  |  BC Extra | Financial News

Europe adds to its IPO queue

Another two European biotech companies have stepped forward as IPO candidates, both looking to list on Nordic exchanges. BioTie Therapies (Turku, Finland) is seeking to raise EUR26.4 million ($24.9 million) through the sale of 3.6...
12:00 AM, Jun 07, 2000  |  BC Extra | Financial News

Personal Chemistry seeks IPO

Personal Chemistry (Uppsala, Sweden), which is developing microwave-assisted chemical synthesis technology, said it hopes to raise SEK 454 million ($51.4 million) through the sale of 4.3 million shares between SEK75 and SEK105 in an IPO...
12:00 AM, Jun 07, 2000  |  BC Extra | Financial News

Genset raises over $46.2 million

Genomics company Genset (NM:Genset; GENXY) raised more than EUR49 million ($46.2 million) by selling zero-coupon convertible bonds with a three-and-a-half year term and a conversion price set at a 17.5 percent premium to the share...
12:00 AM, Jun 06, 2000  |  BC Extra | Financial News

EntreMed raises $11 million

ENMD, which is developing angiogenesis inhibitors to treat cancer, raised $11 million in a warrant exercise. The warrants were issued in a 1999 private placement (see BioCentury, Aug. 2, 1999)....
12:00 AM, Jun 05, 2000  |  BC Extra | Financial News

Genomic Solutions sells partial shoe

GNSL raised $5.3 million through the sale of 660,000 shares at $8 each out of 1.05 million shares authorized to cover overallotments in the company's May IPO. The sale brings to $61.3 million the total...
12:00 AM, Jun 02, 2000  |  BC Extra | Financial News

deCODE ratchets down IPO

deCODE, which filed to raise up to $200 million on March 9, now hopes to raise $112 million to $144 million through the sale of 8 million shares at $14-$18. Morgan Stanley Dean Witter and...

Pages